Member Info for Pingu777

Vlad setting up HG CT 1 nicely and embedding infrastructure for long term production. Read between the lines…

Pumpky,

You tire me out.

You think you are funny with your "but" attitude. You think you can beat the game trading.

But I know I will make a lot more money that you and all by buying HEMO. So I just feel a bit sorry for you that you just cant see why buy and hold now is a move that will make you a lot of dough.

Pitiful chap.

Were you as good at footi as Lewis? Proper player for me.

I'll tell you what, to churn through 300k+ warrants in a week and still finish like a train. We're going to not be far off last Fridays close! Huge volumes and buying.

The risk adjusted returns potential of HEMO improves every day that passes. We get more and more assurance that the treatment is working as the patients remain alive and without a bone marrow transplant. HEMO now has £2m+ in the bank to expedite trials as quickly as MDA can get through in line with the protocol. Previously, this was obviously not the case as finances dictated a more leisurely trial progression.

At this point in my opinion, with the mcap where it is, the downside is minimal and the upside is astronomical. This is prime for any new investors to be stepping in and sitting back for 3-6 months. Existing holders will be topping up where they can.

Upcoming updates due imminently:-

- Patient 3 passing safety. First cohort completion.

- IRB approval at MDA to commence peds trial.

-Recruitment of P4 for second cohort

-Recruitment of child for first injection

-Some formal confirmation of cost-cutting/outsourcing manufacturing as per Linked in clues

And likely many other irons in the fire.

As many have mentioned this is a news rich period that I see transforming HEMO and we will begin to finally get the visibility Vladik's treatments deserve.

Let fomo Friday commence.

Pretty sure you didnt get your price Pumpky.

Now whats the plan?

It would seem that you've forgotten so much you can't remember if its a good investment or not? Enjoy your gamble.

Good luck, go well.

Investing is gambling. But the better the research, the more you know, the better you can assess probability of success and conclude value.

Your post tells me you need to learn about HEMO.

Shady goings on LongShort.

I'm pretty sure this lot, LSE, are complicit as well in it all.

Hulver,

My view exactly. It was all co-ordinated in my opinion.

Not sure what can be done about it mind.

Congratulations on your successful trade pumpky.

But we all know you will go lose your profits rainbow-chasing elsewhere in poor stocks.

Spot on JHFH. I think you've summaries the current position very well.

HEMO is primed with 3 treated patients, their data, cash to expedite the trials and a novel treatment.

Buy, sit back, relax.

Officially traded on LSE 9th of September…Unless

They were forward sold by the broker causing the recent drop.

Figure it out for yourself.

Already forward sold 99% sure

Socialist B

I like HEMO's chances of landing this feature soon as well...

"The value of an FDA Priority Review Voucher (PRV) is the significant financial return from selling it to another company, with recent sales ranging from $100 million to over $150 million, though the market is variable. A company earns a PRV by successfully developing a drug for a rare pediatric or neglected disease and can either use the voucher to accelerate the FDA review for a different drug in their portfolio or sell it to another company."

Socialist B… your AI extract suggests… Exceptional case: **≥70%** durable remissions in a small group would be a game‑changer and could justify approval on very limited numbers.

So three out of three … at 100%…

FDA fast tracks… big pharma big chequebooks just going to let someone else scoop it up?

Interpretation of the data AI supplies is important… do you understand how big this would be?

Patient 1, 8/9 months

Patient 2, 5/6 months

Patient 3, 2/3 months

The statistical trend suggests… what?

Some profit taking after a 400% rise. Who'd have thunk it!

Pumpky, if only you could see past the end of your nose you'd be dangerous.

Better than 16x down.

HEMO is helping the sick. Exactly what Vlad has been striving to do for years.

The share price is (beginning) to follow the science finally. This is just the start.